ReposiTrak (TRAK) Cash & Equivalents (2010 - 2025)

ReposiTrak's Cash & Equivalents history runs 16 years deep, the most recent figure standing at $28.7 million for Q4 2025.

• On a quarterly basis, Cash & Equivalents rose 2.37% year-over-year to $28.7 million in Q4 2025; TTM through Dec 2025 was $28.7 million, a 2.37% increase from a year earlier, with the FY2025 full-year figure at $28.6 million, up 13.58% from the prior year.
• Cash & Equivalents was little changed at $28.7 million in Q4 2025 per TRAK's latest filing, from $28.8 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $28.8 million in Q3 2025 and bottomed at $20.4 million in Q3 2021.
• The 5-year median for Cash & Equivalents is $23.8 million (2023), against an average of $24.3 million.
• Across the five-year window, Cash & Equivalents gained 29.59% in 2021 and dropped 10.84% in 2022, its largest moves.
• Year by year, Cash & Equivalents stood at $21.7 million in 2021, then slipped by 1.42% to $21.4 million in 2022, then increased by 8.66% to $23.3 million in 2023, then climbed by 20.59% to $28.0 million in 2024, then advanced by 2.37% to $28.7 million in 2025.
• Per Business Quant, the three latest TRAK Cash & Equivalents figures stand at $28.7 million (Q4 2025), $28.8 million (Q3 2025), and $28.6 million (Q2 2025).